Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center talks of his hopes for the expansion of talimogene laherparepvec across multiple cancer types for future clinical research. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.